Restructuring of Overseas Business Portfolio
First written in FY2018-Q2. 7 of 9 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2022: 2 of 9 companies on the "Worse" side.
15 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「With respect to the overseas business, the Company has begun a fundamental review of the business based on criteria including future growth potential and profitability.」
The Company began a fundamental review of the overseas business based on growth potential and profitability. In addition, SENIOR MARKETING SYSTEM ASIA PTE. LTD. was excluded from the scope of consolidation following completion of its liquidation. - FY2025AdvancedAnnual report
「CCM RECRUITMENT SERVICES LIMITED was excluded from the scope of consolidation from the current consolidated fiscal year following completion of its liquidation.」
As part of the overseas business portfolio streamlining, liquidation of CCM RECRUITMENT SERVICES LIMITED was completed and the company was excluded from the scope of consolidation. - FY2021-Q1AdvancedAnnual report
「Elimination of the temporary impacts and other effects arising from reorganizing Medilabs, which provides career services for nurses in South Korea, under MIMS in March 2019 and changing the timing of consolidation.」
The temporary impacts and other effects associated with reorganizing Medilabs under MIMS and changing the timing of consolidation are reported to have been eliminated. - FY2020-Q3RestatedAnnual report
「Revenue decreased year on year due to the impact of reorganizing Medilabs, which operates a career service for nurses in South Korea, under MIMS in March 2019 and changing the timing of consolidation, as well as the lengthening of lead times before travel following changes to travel authorization procedures for referring healthcare professionals in Malaysia to medical institutions in Saudi Arabia.」
The impact of reorganizing Medilabs under MIMS and changing the timing of consolidation is reaffirmed as an impact associated with the overseas business portfolio restructuring. - FY2020-Q2AdvancedAnnual report
「Revenue decreased year on year due to the impact of reorganizing Medilabs, which operates a career service for nurses in South Korea, under MIMS in March 2019 and changing the timing of consolidation, as well as the lengthening of lead times before travel following changes to travel authorization procedures for referring healthcare professionals in Malaysia to medical institutions in Saudi Arabia.」
Medilabs in South Korea was reorganized under MIMS and the timing of consolidation was changed. The accounting impact associated with the overseas business portfolio restructuring is reported. - FY2018-Q2First statedAnnual report
「In the overseas business, revenue decreased from the same period of the previous year, mainly because subsidiaries including eChannelling were sold as part of the overseas business portfolio restructuring carried out in the previous fiscal year, and because the timing of revenue recognition changed following a change in the timing of MIMS Book provision.」
The overseas business portfolio restructuring was explicitly identified, with the sale of subsidiaries including eChannelling stated as the means of implementation.